DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
173 hedge funds and large institutions have $1.4B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
173
Holders Change
+1
Holders Change %
+0.58%
% of All Funds
3.07%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
28
Increased
56
Reduced
66
Closed
27
Calls
$1.51M
Puts
$4.79M
Net Calls
-$3.28M
Net Calls Change
+$5.06M
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$52.1M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$48.5M |
| 3 |
WP
3
Woodline Partners
San Francisco,
California
|
$29.9M |
| 4 |
CCM
4
CAAS Capital Management
New York
|
$10.8M |
| 5 |
5
Goldman Sachs
New York
|
$23.8M |
